STK002

搜索文档
Stoke Therapeutics(STOK) - 2025 Q2 - Earnings Call Transcript
2025-08-13 05:30
Stoke Therapeutics (STOK) Q2 2025 Earnings Call August 12, 2025 04:30 PM ET Speaker0Good afternoon and welcome to Stokes Therapeutics second quarter twenty twenty five conference call. I'm Tommy Leggett, Chief Financial Officer at Stokes. Joining me for prepared remarks are Ian Smith, our Interim Chief Executive Officer Doctor. Barry Tico, Chief Medical Officer and Doctor. Kimberly Parkerson, Head of Neurology Clinical Development.In addition, Jason Hoyt, our Chief Patient Officer will participate in Q and ...